欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号FR/V/0354/001
药品名称Sympagesic 500 mg/ml + 4 mg/ml solution for injection for horses, cattle, pigs and dogs
活性成分
    • metamizole sodium 4.0 mg/ml
    • SCOPOLAMINE butylbromide 500.0 mg/ml
剂型Solution for injection
上市许可持有人Dechra Regulatory B.V.
参考成员国 - 产品名称France (FR)
SYMPAGESIC SOLUTION INJECTABLE POUR CHEVAUX, BOVINS, PORCINS ET CHIENS
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
      Hyozole Vet.
    • Belgium (BE)
      Sympagesic 500 mg/ml + 4 mg/ml
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
      Sympagesic 500 mg/ml + 4 mg/ml stungulyf, lausn handa hestum, nautgripum, svínum og hundum
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
      Sympagesic
    • Finland (FI)
    • Poland (PL)
    • Latvia (LV)
      Sympagesic 500 mg/ml + 4 mg/ml šķīdums injekcijām zirgiem, liellopiem, cūkām un suņiem
    • Lithuania (LT)
    • Estonia (EE)
      Sympagesic
    • Hungary (HU)
    • Bulgaria (BG)
    • Cyprus (CY)
    • Czechia (CZ)
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Croatia (HR)
许可日期2019/03/13
最近更新日期2020/03/20
药物ATC编码
    • QA03DB04 butylscopolamine and analgesics
申请类型
  • TypeLevel1:food
  • TypeLevel2:Pharmaceutical
  • TypeLevel3:Generic - art 13.2 Dir 2001/82/EC
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase